Wearable Devices Ltd. Sells 252,000 Shares in Direct Offering

TL;DR

Wearable Devices Ltd. just sold 252k shares to an institution via direct offering. 20-F filing confirmed.

AI Summary

On November 26, 2024, Wearable Devices Ltd. entered into a Securities Purchase Agreement with an institutional investor to sell 252,000 ordinary shares in a registered direct offering. The filing also indicates the company will file its annual report on Form 20-F.

Why It Matters

This registered direct offering provides capital to Wearable Devices Ltd. by selling shares directly to an institutional investor, impacting its financial structure and potentially its stock price.

Risk Assessment

Risk Level: medium — Direct offerings can dilute existing shareholders and signal a need for capital, potentially impacting stock price and future performance.

Key Numbers

• 252,000 — Ordinary Shares (Number of shares sold in the registered direct offering)

Key Players & Entities

• Wearable Devices Ltd. (company) — Filer of the 6-K report and seller of shares
• November 26, 2024 (date) — Date of the Securities Purchase Agreement
• 252,000 (dollar_amount) — Number of ordinary shares to be sold

FAQ

Key Financial Figures

• $2.25 — Shares”), at an offering price of $2.25 per share; and (ii) pre-funded warrants
• $2.2499 — arrants”) at an offering price of $2.2499 per Pre-Funded Warrant. The Pre-Funded
• $0.0001 — Ordinary Share at an exercise price of $0.0001 per share. The Pre-Funded Warrants are
• $2.50 — y upon issuance at an exercise price of $2.50 per Ordinary Share and will expire on t
• $35,000 — the offering in an amount not to exceed $35,000. The foregoing summaries of the Placem
• $1.85 Million — rable Devices Ltd. Announces Pricing of $1.85 Million Registered Direct Offering and Concurre

Filing Documents

• ea0222722-6k_wearable.htm (6-K) — 27KB
• ea022272201ex4-1_wearable.htm (EX-4.1) — 92KB
• ea022272201ex4-2_wearable.htm (EX-4.2) — 83KB
• ea022272201ex5-1_wearable.htm (EX-5.1) — 11KB
• ea022272201ex5-2_wearable.htm (EX-5.2) — 12KB
• ea022272201ex10-1_wearable.htm (EX-10.1) — 48KB
• ea022272201ex10-2_wearable.htm (EX-10.2) — 227KB
• ea022272201ex99-1_wearable.htm (EX-99.1) — 12KB
• ex5-1_001.jpg (GRAPHIC) — 8KB
• ex5-2_001.jpg (GRAPHIC) — 8KB
• ex5-2_002.jpg (GRAPHIC) — 6KB
• 0001213900-24-103113.txt ( ) — 542KB

Forward-Looking Statements

Forward-Looking Statements : This Report contains forward-looking other Federal securities laws. For example, the Company is using forward-looking statements when it discusses the closing of the Offering. All statements other than statements of historical facts included in this Report are forward-looking statements. Forward-looking statements are neither historical facts nor assurances of future performance. Instead, they are based only on the Company’s current beliefs, expectations and assumptions regarding the future of its business, future plans and strategies, projections, anticipated events and trends, the economy and other future conditions. Because forward-looking statements relate to the future, they are subject to inherent uncertainties, risks and changes in circumstances that are difficult to predict and many of which are outside of the Company’s control. The Company’s actual results and financial condition may differ materially from those indicated in the forward-looking statements. Therefore, you should not rely on any of these forward-looking statements. Important factors that could cause our actual results and financial condition to differ materially from those indicated in the forward-looking statements include the risks and uncertainties described in the Company’s annual report on Form 20-F for the year ended December 31, 2023, filed with the Commission on March 15, 2024, and the Company’s other filings with the Commission. The Company undertakes no obligation to publicly update any forward-looking statement, whether written or oral, that may be made from time to time, whether as a result of new information, future developments or otherwise. 2 EXHIBIT INDEX Exhibit No. Description 4.1 Form of Ordinary Warrant. 4.2 Form of Pre-Funded Warrant. 5.1 Opinion of Sullivan & Wo

SIGNATURES

SIGNATURES Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned, thereunto duly authorized. Wearable Devices Ltd. Date: November 27, 2024 By: /s/ Asher Dahan Asher Dahan Chief Executive Officer 4

View Full Filing

View this 6-K filing on SEC EDGAR